Skip to main content

Table 1 ADC values of tumour entities and subgroups at baseline and during follow-up

From: Quantitative DWI predicts event-free survival in children with neuroblastic tumours: preliminary findings from a retrospective cohort study

 

ADC baseline

ADC follow-up

NB all

n = 15

n = 11

0.76 ± 0.11

0.89 ± 0.29

(0.58–0.95)

(0.49–1.49)

GNB + GN

n = 4

n = 2

1.47 ± 0.23

GNB 0.90

(1.15–1.69)

GN 1.84

NB with therapy

n = 6

n = 5

0.70 ± 0.08

0.71 ± 0.25

(0.58–0.79)

(0.49–1.14)

NB with observation

n = 7

n = 4

0.82 ± 0.09

0.93 ± 0.12

(0.65–0.95)

(0.77–1.06)

NB with risk factors

n = 6

n = 5

0.70 ± 0.08

0.72 ± 0.25

(0.58–0.79)

(0.78–1.50)

NB without risk factors

n = 9

n = 7

0.79 ± 0.11

1.04 ± 0.23

(0.59–0.95)

(0.77–1.50)

  1. ADC apparent diffusion coefficient, GN ganglioneuroma, GNB ganglioneuroblastoma, NB neuroblastoma
  2. Data is presented as mean ± standard deviation and range (minimum–maximum)